New Key Statistics Module, Z-Score and F-Score
OTCPK:SMPQY Key Ratios
| Market Cap $ M | -- |
| Enterprise Value $ M | 16,422.49 |
| P/E(ttm) | 43.81 |
| PE Ratio without NRI | 43.49 |
| Forward PE Ratio | 37.31 |
| Price/Book | 7.15 |
| Price/Sales | 9.38 |
| Price/Free Cash Flow | 45.82 |
| Price/Owner Earnings | 37.07 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -2.59 |
| 10-y EBITDA Growth Rate % | 4.10 |
| 5-y EBITDA Growth Rate % | 18.40 |
| y-y EBITDA Growth Rate % | 19.30 |
| EV-to-EBIT | 35.85 |
| EV-to-EBITDA | 29.65 |
| PEG | 2.36 |
| Shares Outstanding M | 2,399.33 |
| Net Margin (%) | 21.42 |
| Operating Margin % | 22.25 |
| Pre-tax Margin (%) | 24.81 |
| Quick Ratio | 1.98 |
| Current Ratio | 2.56 |
| ROA % (ttm) | 12.69 |
| ROE % (ttm) | 17.37 |
| ROIC % (ttm) | 16.17 |
| Dividend Yield % | -- |
| Altman Z-Score | 17.11 |
SMPQY Number of Guru Trades
SMPQY Volume of Guru Trades
Gurus Latest Trades with OTCPK:SMPQY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SMPQY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sun Pharmaceuticals Industries Ltd Insider Transactions
No Available Data
News about OTCPK:SMPQY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers